Ionis Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IONS and other ETFs, options, and stocks.

About IONS

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T. 

CEO
Brett P. Monia
CEOBrett P. Monia
Employees
1,069
Employees1,069
Headquarters
Carlsbad, California
HeadquartersCarlsbad, California
Founded
1989
Founded1989
Employees
1,069
Employees1,069

IONS Key Statistics

Market cap
10.44B
Market cap10.44B
Price-Earnings ratio
-34.64
Price-Earnings ratio-34.64
Dividend yield
Dividend yield
Average volume
2.00M
Average volume2.00M
High today
$65.55
High today$65.55
Low today
$63.66
Low today$63.66
Open price
$63.86
Open price$63.86
Volume
1.39M
Volume1.39M
52 Week high
$65.55
52 Week high$65.55
52 Week low
$23.95
52 Week low$23.95

IONS News

Simply Wall St 3d
Is Ionis Pharmaceuticals Still Attractive After 85% Rally and ALS Drug Approval?

If you have been watching Ionis Pharmaceuticals lately, you are definitely not alone. The stock is having quite the run, up 5% in the past week and nearly 50% i...

Is Ionis Pharmaceuticals Still Attractive After 85% Rally and ALS Drug Approval?
TipRanks 4d
Ionis Pharmaceuticals upgraded to Neutral from Sell at Goldman Sachs

Goldman Sachs analyst Salveen Richter upgraded Ionis Pharmaceuticals (IONS) to Neutral from Sell with a price target of $65, up from $45. The firm says Ionis is...

Analyst ratings

74%

of 27 ratings
Buy
74.1%
Hold
25.9%
Sell
0%

People also own

Based on the portfolios of people who own IONS. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.